Low contralateral neck recurrence risk with ipsilateral neck radiotherapy in N2b tonsillar squamous cell carcinoma.

[1]  A. Garden,et al.  Unilateral Radiotherapy for Tonsillar Cancer: Treatment Outcomes in the Era of Human Papilloma Virus (HPV), Positron-emission Tomography (PET) and Intensity-modulated Radiation Therapy (IMRT). , 2022, International journal of radiation oncology, biology, physics.

[2]  Steven S. Chang,et al.  Ipsilateral radiation for squamous cell carcinoma of the tonsil: American Radium Society appropriate use criteria executive summary , 2020, Head & neck.

[3]  T. Roques,et al.  Ipsilateral neck radiotherapy in N2b well‐lateralized tonsil cancer – Approach with caution , 2019, Head & neck.

[4]  J. Kazmierska,et al.  Selection of lymph node target volumes for definitive head and neck radiation therapy: a 2019 Update. , 2019, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[5]  W. Thorstad,et al.  Comparison of unilateral versus bilateral intensity‐modulated radiotherapy for surgically treated squamous cell carcinoma of the palatine tonsil , 2017, Cancer.

[6]  J. Waldron,et al.  Radiation Therapy for Oropharyngeal Squamous Cell Carcinoma: American Society of Clinical Oncology Endorsement of the American Society for Radiation Oncology Evidence-Based Clinical Practice Guideline. , 2017, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[7]  J. Waldron,et al.  Re-evaluation of Ipsilateral Radiation for T1-T2N0-N2b Tonsil Carcinoma at the Princess Margaret Hospital in the Human Papillomavirus Era, 25 Years Later. , 2017, International journal of radiation oncology, biology, physics.

[8]  M. Urken,et al.  Low rates of contralateral neck failure in unilaterally treated oropharyngeal squamous cell carcinoma with prospectively defined criteria of lateralization , 2017, Head & neck.

[9]  Sang‐wook Lee,et al.  Comparison of the Clinical Outcomes of Patients with Squamous Cell Carcinoma of the Tonsil Receiving Postoperative Ipsilateral Versus Bilateral Neck Radiotherapy: A Propensity Score Matching Analysis (KROG 11-07) , 2017, Cancer research and treatment : official journal of Korean Cancer Association.

[10]  F. Alongi,et al.  Role of fluorine-18 fluorodeoxyglucose PET/CT in head and neck oncology: the point of view of the radiation oncologist. , 2016, The British journal of radiology.

[11]  W. Mendenhall,et al.  Ipsilateral radiotherapy for squamous cell carcinoma of the tonsil , 2016, European Archives of Oto-Rhino-Laryngology.

[12]  S. Bhide,et al.  Multiple cervical lymph node involvement and extra-capsular extension predict for contralateral nodal recurrence after ipsilateral radiotherapy for squamous cell carcinoma of the tonsil. , 2014, Oral oncology.

[13]  Joshua D. Lawson,et al.  ACR appropriateness criteria® ipsilateral radiation for squamous cell carcinoma of the tonsil , 2012, Head & neck.

[14]  B. Panizza,et al.  Results of a prospective study of positron emission tomography–directed management of residual nodal abnormalities in node‐positive head and neck cancer after definitive radiotherapy with or without systemic therapy , 2011, Head & neck.

[15]  C. Grau,et al.  Morbidity after ipsilateral radiotherapy for oropharyngeal cancer. , 2007, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.

[16]  P. Levendag,et al.  Unilateral neck irradiation for well-lateralized oropharyngeal cancer. , 2013, Radiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology.